While everyone else is getting ready for football season, Sean, Tyler and Taylor are drafting energy stocks this week with our first ever energy stock fantasy draft.

The diabetes pandemic and medical marijuana are two of the healthcare's biggest trends, but not all diabetes or marijuana stocks are likely to succeed. The Motley Fool's Kristine Harjes and Todd Campbell explain what you need to consider before investing in these growing markets.

Following the underwhelming debut of its Keurig 2.0, Keurig Green Mountain has pegged its future success to the Kold beverage system.

Meanwhile, Skullcandy moves forward with its expansion efforts as its multi-year turnaround seemingly takes hold. With both stocks suffering significant losses year-to-date, is this the right time for investors to buy?

While the broader market has begun to stabilize after macro concerns pushed down stocks the past two weeks, there are still several tech companies that have yet to rebound, thanks to some idiosyncratic concerns. Are these companies bargains for a reason, or do they belong on your watchlist?

On this energy edition of Industry Focus we take a look at what's going on with oil prices, how its impacting producers, and what investors can do about it.